Imperagen
Closed-loop, AI-guided enzyme engineering
Manchester, United Kingdom · Founded 2021 · $6.5M raised
- Headquarters
- Manchester
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- imperagen.com
- Total Funding
- $6.5M
- Last Round
- $6.5M Venture RoundMay 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Imperagen is a Manchester-based techbio company founded in November 2021 by researchers from the University of Manchester's Institute of Biotechnology. Its closed-loop platform combines quantum physics-based AI simulation with high-throughput automated lab testing to engineer improved enzymes faster and at lower cost. The company closed a £5 million seed round in May 2026.
Summary
Imperagen is a Biotech company based in Manchester, United Kingdom, founded in 2021. It has raised $6.5M in total across 1 round, most recently a $6.5M Venture Round in May 2026.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2026
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/imperagen"><img src="https://indexed.vc/api/badge/company/imperagen" alt="Imperagen on Indexed.vc" width="260" height="76" /></a>